M
Marrone Bio Innovations Inc
F:0MB
Marrone Bio Innovations Inc
F:0MB
Price:
0.965
EUR
-3.02%
Market Closed
Market Cap:
€176m
Balance Sheet
Balance Sheet Decomposition
Marrone Bio Innovations Inc
Marrone Bio Innovations Inc
Balance Sheet Decomposition is not available for
Marrone Bio Innovations Inc
Marrone Bio Innovations Inc
Balance Sheet
Marrone Bio Innovations Inc
Marrone Bio Innovations Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
10
|
24
|
35
|
20
|
10
|
1
|
18
|
6
|
16
|
20
|
|
| Cash Equivalents |
10
|
24
|
35
|
20
|
10
|
1
|
18
|
6
|
16
|
20
|
|
| Short-Term Investments |
0
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
3
|
5
|
2
|
2
|
4
|
4
|
3
|
6
|
10
|
13
|
|
| Accounts Receivables |
3
|
5
|
2
|
2
|
4
|
4
|
3
|
6
|
10
|
13
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
5
|
13
|
13
|
9
|
8
|
10
|
8
|
8
|
7
|
9
|
|
| Other Current Assets |
10
|
4
|
5
|
5
|
5
|
5
|
1
|
1
|
2
|
1
|
|
| Total Current Assets |
27
|
60
|
55
|
36
|
27
|
19
|
30
|
22
|
34
|
43
|
|
| PP&E Net |
4
|
9
|
20
|
18
|
17
|
16
|
15
|
18
|
16
|
16
|
|
| PP&E Gross |
4
|
9
|
20
|
18
|
17
|
16
|
0
|
18
|
16
|
16
|
|
| Accumulated Depreciation |
2
|
3
|
5
|
7
|
7
|
9
|
0
|
13
|
14
|
15
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
21
|
19
|
|
| Other Long-Term Assets |
3
|
1
|
2
|
17
|
2
|
2
|
2
|
3
|
2
|
2
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
7
|
|
| Total Assets |
34
N/A
|
70
+107%
|
77
+10%
|
71
-8%
|
46
-35%
|
37
-20%
|
47
+26%
|
73
+56%
|
81
+12%
|
87
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
4
|
6
|
2
|
1
|
4
|
2
|
3
|
2
|
3
|
|
| Accrued Liabilities |
3
|
5
|
6
|
7
|
7
|
10
|
7
|
13
|
13
|
16
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
31
|
2
|
14
|
1
|
1
|
2
|
2
|
4
|
9
|
26
|
|
| Other Current Liabilities |
3
|
5
|
5
|
3
|
6
|
7
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
39
|
16
|
31
|
13
|
15
|
22
|
11
|
21
|
24
|
45
|
|
| Long-Term Debt |
27
|
13
|
10
|
57
|
58
|
62
|
19
|
19
|
19
|
8
|
|
| Other Liabilities |
2
|
2
|
3
|
3
|
3
|
3
|
3
|
9
|
7
|
5
|
|
| Total Liabilities |
68
N/A
|
31
-55%
|
44
+42%
|
73
+67%
|
76
+4%
|
88
+15%
|
34
-62%
|
49
+46%
|
50
+1%
|
57
+15%
|
|
| Equity | |||||||||||
| Common Stock |
40
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
76
|
108
|
160
|
204
|
235
|
266
|
283
|
321
|
341
|
357
|
|
| Additional Paid In Capital |
1
|
147
|
193
|
202
|
204
|
215
|
296
|
344
|
372
|
387
|
|
| Total Equity |
35
N/A
|
39
N/A
|
33
-15%
|
2
N/A
|
30
-1 394%
|
51
-68%
|
13
N/A
|
24
+82%
|
31
+33%
|
30
-6%
|
|
| Total Liabilities & Equity |
34
N/A
|
70
+107%
|
77
+10%
|
71
-8%
|
46
-35%
|
37
-20%
|
47
+26%
|
73
+56%
|
81
+12%
|
87
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
4
|
19
|
24
|
25
|
25
|
31
|
111
|
140
|
167
|
182
|
|
Switch to:
Switch to:
See Also
Discover More
